Filter By Category
Archives
Share on -
BECAPLERMIN
Generic Name: BECAPLERMIN
ABSTRACT -
Becaplermin is a recombinant human platelet-derived growth factor-BB. Current status: approved topical wound-healing biologic. Mechanistic summary: stimulates chemotaxis and proliferation of cells involved in wound repair. This document is for structured API information only and is not a prescribing guide. Clinical use, if any, must follow the approved local label, institutional protocol, and specialist medical judgment.
DOSAGE-
- Apply topically only according to the approved wound-care label.
- Use with good ulcer care, off-loading, debridement when needed, and infection control.
- Do not use as a substitute for surgical or vascular assessment when clinically needed.
SIDE EFFECTS-
Possible side effects and safety concerns include:
- Injection-site or application-site reaction
- Fluid retention, pain, fever, or constitutional symptoms
- Immune response to the recombinant protein or fusion protein
- Target-related laboratory changes
ALLERGIC REACTIONS -
Hypersensitivity to Becaplermin or related products may occur. Symptoms may include:
- Urticaria, generalized rash, itching, flushing, or fever
- Facial, lip, tongue, or throat swelling
- Wheezing, chest tightness, shortness of breath, dizziness, or collapse
- Anaphylaxis requiring emergency treatment
Important: patients with suspected allergy to Becaplermin should seek immediate medical attention and inform future healthcare providers.
DRUG INTERACTIONS-
Becaplermin may interact with medicines, biologics, vaccines, supplements, procedures, or clinical conditions. Caution is needed with:
- Other biologics with overlapping pathway effects may alter safety.
- Immunosuppressive therapy may affect response or infection risk.
- Concomitant local therapies should follow label or protocol instructions.
Patients should provide a complete medicine list, including prescription drugs, over-the-counter products, herbal medicines, vaccines, and supplements.
PREAUTIONS–
- Use aseptic technique and product-specific storage/reconstitution instructions.
- Monitor immune reactions, target-pathway markers, and route-specific local reactions.
- Avoid substitution between biologic products without prescriber oversight.
WARNINGS –
- Use only for appropriate lower-extremity diabetic ulcers with good wound care; avoid use in known neoplasm at the application site.
- Serious hypersensitivity or immune-mediated reactions may occur with biologic exposure.
- Do not use without qualified medical supervision, approved labeling, or a formal clinical-trial protocol.
- Keep out of reach of children.
Share on -
. Developed by